Sodium Polystyrene Sulfonate
Sodium Polystyrene Sulfonate for Suspension
Approved
Approval ID
3423d014-4c35-441a-8528-2a7bc050f809
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 9, 2023
Manufacturers
FDA
Marlex Pharmaceuticals Inc
DUNS: 782540215
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
sodium polystyrene sulfonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10135-146
Application NumberANDA204071
Product Classification
M
Marketing Category
C73584
G
Generic Name
sodium polystyrene sulfonate
Product Specifications
Route of AdministrationORAL, RECTAL
Effective DateNovember 9, 2023
FDA Product Classification
INGREDIENTS (1)
SODIUM POLYSTYRENE SULFONATEActive
Quantity: 4.1 meq in 1 g
Code: 1699G8679Z
Classification: ACTIR